Subjects With an Ileostomy Clinical Trial
Official title:
Investigating the Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy
| Verified date | July 2014 |
| Source | Coloplast A/S |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Denmark: Danish Health and Medicines Authority |
| Study type | Interventional |
The aim of the current clinical investigation is to evaluate the performance and safety of new 2-piece ostomy product concepts.
| Status | Completed |
| Enrollment | 31 |
| Est. completion date | April 2013 |
| Est. primary completion date | April 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Have given written informed consent and signed letter of authority form. 2. Be at least 18 years of age and have full legal capacity. 3. Be able to handle the appliances themselves 4. Have an ileostomy with a diameter between 15 and 40 mm. 5. Have had their ostomy for at least three months. 6. Use minimum 1 baseplate every third day. 7. Currently use 2-piece flat mechanical coupling product with open bag and a coupling size in the inter val of 43-55mm (both extremes included) 8. Must be able to use custom cut product 9. Accept to test three 2-piece products within the study. 10. Negative result of a pregnancy test for women of childbearing age. Exclusion Criteria: 1. Use irrigation during the study (flush the stoma with water). 2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy. 3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area. 4. Are pregnant or breastfeeding. 5. Participating in other interventional clinical investigations or have previously participated in this investigation. 6. More than three days wear time as usual change pattern. 7. Currently using ostomy belt 8. Currently using extended wear product (Sensura Xpro, Assura TERA, Dansac NovaLife X3, Hollister Flextend, Convatec Durahesive) 9. Have a loop ileostomy 10. Known hypersensitivity towards any of the test products 11. Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Coloplast A/S | Humlebæk |
| Lead Sponsor | Collaborator |
|---|---|
| Coloplast A/S |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Degree of Leakage | The degree of leakage is assessed using a 4 point leakage scale developed by Coloplast A/S. The 4-point leakage scale has four choices No leakage Starting to leakage Leakage Sudden leakage Leakage was assessed at every baseplate change |
10 days | No |